Identification of GPR52 antagonists as potential treatments for Huntington Disease
Identification of GPR52 antagonists as potential treatments for Huntington Disease
批准号:
9205646
负责人:
Marc Ferrer
金额:
$1.9万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
During this period, the NCGC has fostered and maintained over 180 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to over 100 high-throughput screens and nearly 60 medicinal chemistry campaigns, providing our collaborators and the general research community a wealth of publications and promising small molecule leads. In addition, the NCGC has undertaken a number of informatic challenges to make better use of existing drug and disease target information and provide the general public with easily accessible resources, further catalyzing the development of new therapies for human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent
-
批准号:9205645
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinted Omentum tissue to model ovarian cancer metastasis
-
批准号:10683668
-
项目类别:
-
资助金额:$90.89万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinted retina models for drug screening
-
批准号:10916043
-
项目类别:
-
资助金额:$226.91万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinted lung cancer models for drug screening
-
批准号:10907367
-
项目类别:
-
资助金额:$226.91万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Targeting Tumor-derived exRNA-Containing microvesicles by high throughput screening
-
批准号:9359917
-
项目类别:
-
资助金额:$15.8万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery
-
批准号:9355001
-
项目类别:
-
资助金额:$301.07万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of Small Molecule Effectors that target the Fungal-Specific Kinase Drk1 as Novel Antifungal Drug Leads
-
批准号:9205652
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
PAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress
-
批准号:9360500
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of Small Molecule Inhibitors of PHF5A for Glioblastoma
-
批准号:9360504
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Small molecule inhibitor screen of MHC II processing pathways using influenza virus A/PR/8/34
-
批准号:9205649
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
High-throughput screens for compounds that reverse cellular toxicity of neurodegenerative disease-associated proteins in yeast models (alpha-synuclein)
-
批准号:9205648
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
A drug-screening platform for autism spectrum disorders using human neurons and astrocytes
-
批准号:9205632
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
HTS screening for inhibitors of HPV 16 E6/caspase 8 binding
-
批准号:9205653
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of small molecule inhibitors of miR-155 expression in Th17 cells
-
批准号:9205636
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Adaptation of an Organotypic 3 Dimensional Culture for High-Throughput Screening
-
批准号:9205647
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
3D Bioprinted skin models for drug screening
-
批准号:10683670
-
项目类别:
-
资助金额:$90.89万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses
-
批准号:10907368
-
项目类别:
-
资助金额:$10.18万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of small molecule inhibitors of Neutral Sphingomyelinase 2 (nSMase2) as a new therapeutic approach for the treatment of neurodegenerative disorders
-
批准号:9360493
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
A Novel Cell-Based Assay to Identify Small Molecules for Galactocerebrosidase (GALC)
-
批准号:9360503
-
项目类别:
-
资助金额:$3.75万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
Identification of small molecules that decrease the activity of the huntingtin gene promoter for the potential treatment of Huntington Disease
-
批准号:9205664
-
项目类别:
-
资助金额:$1.9万
-
财政年份:--
-
负责人:Marc Ferrer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新型GPR52小分子抑制剂的设计合成
-
批准号:82304307
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:张玉芳
-
依托单位:
孤儿G蛋白偶联受体GPR52负向别构调控剂设计和机制研究
-
批准号:22107072
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:吴屹然
-
依托单位:
特异抑制G蛋白偶联受体GPR52的全合成人源化纳米抗体的鉴定及验证
-
批准号:32070939
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:丁澦
-
依托单位:
靶向GPR52对亨廷顿病潜在治疗作用的研究
-
批准号:81870990
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2018
-
负责人:鲁伯埙
-
依托单位:
GPR52调控变异HTT蛋白水平的验证与机制研究
-
批准号:31371421
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:鲁伯埙
-
依托单位: